phosphotyrosine has been researched along with Acute Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrera, AZ; Bas, M; Chen, X; Dong, G; Hofauer, B; Hou, Y; Ji, Y; Jiao, Y; Knopf, A; Li, F; Li, Q; Li, W; Li, Z; Liu, Z; Lu, X; Ma, F; Mansour, N; Muñoz, RF; Ng, R; Ren, D; Ren, J; Song, G; Steer, CJ; Stock, KF; Strassen, U; Tang, R; Wickham, RE; Wu, H; Xu, Y; You, M; Yue, H; Zhang, H | 1 |
| Drexler, HG; Quentmeier, H; Reinhardt, J; Zaborski, M | 1 |
| Allebach, J; Brown, P; Chen, P; Kim, KT; Levis, M; Small, D | 1 |
| Abe, A; Emi, N; Hayakawa, F; Kiyoi, H; Miyata, Y; Naoe, T; Okamoto, M; Towatari, M; Watamoto, K | 1 |
| Gu, TL; Macneill, J; Nardone, J; Nimer, SD; Polakiewicz, RD; Popova, L; Reeves, C; Rush, J | 1 |
| Chung, EJ; Kajiguchi, T; Kiyoi, H; Lee, S; Levis, MJ; Naoe, T; Neckers, L; Stine, A; Trepel, JB | 1 |
| Barnekow, A; Büchner, T; Cassens, U; Koch, OM; Kremerskothen, J; Müller, C; Zühlsdorf, M | 1 |
| Feldman, RA; Jücker, M; Schiffer, CA | 1 |
| Bonmann, M; Cassens, U; Koch, OM; Müller, C | 1 |
| Kruijer, W; Schuringa, JJ; Vellenga, E; Wierenga, AT | 1 |
10 other study(ies) available for phosphotyrosine and Acute Disease
| Article | Year |
|---|---|
Topics: Acute Disease; Adenoma; Adenoma, Pleomorphic; Adolescent; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Animals; Antigens, CD; B-Lymphocytes; Carcinogenesis; Carcinoma, Hepatocellular; CD4-Positive T-Lymphocytes; Diet, High-Fat; Down-Regulation; Elasticity Imaging Techniques; Female; Gene Expression Profiling; Gene Expression Regulation; Hep G2 Cells; HIV Infections; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Integrins; Interferon-alpha; Lipid Metabolism; Liver; Liver Neoplasms; Lupus Erythematosus, Systemic; Lymphocyte Depletion; Lymphocyte Subsets; Male; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; MicroRNAs; Middle Aged; Multimodal Imaging; Non-alcoholic Fatty Liver Disease; Oligonucleotides, Antisense; Parotid Gland; Parotid Neoplasms; Phenotype; Phosphatidylinositol 3-Kinases; Phosphotyrosine; Predictive Value of Tests; Protein-Tyrosine Kinases; Reoperation; Signal Transduction; Spleen; src-Family Kinases; STAT2 Transcription Factor; Sterol Regulatory Element Binding Protein 1; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Toll-Like Receptor 7; Toll-Like Receptor 9; Tumor Suppressor Protein p53; Ultrasonography, Doppler, Color; Young Adult | 2015 |
FLT3 mutations in acute myeloid leukemia cell lines.
Topics: Acute Disease; Base Sequence; Blotting, Western; Cell Transformation, Neoplastic; DNA-Binding Proteins; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid; Milk Proteins; Molecular Sequence Data; Phosphorylation; Phosphotyrosine; Point Mutation; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptors, Cell Surface; Signal Transduction; STAT5 Transcription Factor; Tandem Repeat Sequences; Thymidine; Trans-Activators; Tumor Cells, Cultured | 2003 |
FLT3/ITD mutation signaling includes suppression of SHP-1.
Topics: Acute Disease; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; fms-Like Tyrosine Kinase 3; Furans; Humans; Hydrolysis; Indoles; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid; Mutation; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; RNA Interference; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Vanadates | 2005 |
Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD.
Topics: Acute Disease; Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Line; Drug Design; Drug Screening Assays, Antitumor; Female; fms-Like Tyrosine Kinase 3; Hematopoietic Stem Cells; Leukemia, Myeloid; Membrane Proteins; Mice; Mice, Inbred C3H; Molecular Sequence Data; Mutant Proteins; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrimidines; Recombinant Fusion Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; src-Family Kinases; STAT5 Transcription Factor; Tandem Repeat Sequences; Transfection | 2007 |
Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia.
Topics: Acute Disease; Biomarkers, Tumor; Cell Line, Tumor; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 15; Humans; Leukemia, Myeloid; Neoplasm Proteins; Oncogene Proteins, Fusion; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Protein Structure, Tertiary; Protein-Tyrosine Kinases; RNA, Small Interfering; STAT5 Transcription Factor; Translocation, Genetic | 2007 |
FLT3 regulates beta-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells.
Topics: Active Transport, Cell Nucleus; Acute Disease; Animals; beta Catenin; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Leukemic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Interleukin-3; Leukemia, Myeloid; Membrane Proteins; Mice; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Recombinant Proteins; RNA, Small Interfering; Staurosporine; Transcription, Genetic; Tyrphostins | 2007 |
Rapid quantitative analysis of protein tyrosine residue phosphorylation in defined cell populations in whole blood and bone marrow aspirates.
Topics: Acute Disease; Bone Marrow; Flow Cytometry; Hematologic Tests; Humans; Leukemia, Myeloid; Phosphorylation; Phosphotyrosine | 1996 |
A tyrosine-phosphorylated protein of 140 kD is constitutively associated with the phosphotyrosine binding domain of Shc and the SH3 domains of Grb2 in acute myeloid leukemia cells.
Topics: Acute Disease; Animals; ErbB Receptors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Mice; Molecular Weight; Phosphorylation; Phosphotyrosine; Protein Binding; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptor, trkA; Receptors, Nerve Growth Factor; src Homology Domains; Tumor Cells, Cultured | 1997 |
Flow cytometric analysis of protein phosphorylation in the hematopoetic system.
Topics: Acute Disease; Adult; Flow Cytometry; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Lymphocytes; Monocytes; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Tyrosine | 1998 |
Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6.
Topics: Acute Disease; Carrier Proteins; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid; Phosphorylation; Phosphoserine; Phosphotyrosine; Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Trans-Activators; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 2000 |